Hyun Tae Lee (Hyun-Tae Lee)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Single Molecule

Drug Administration

Epidermal Growth Factor Receptor

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Tae-Jun Jeong, Hyun Tae Lee, Nahyeon Gu, Yu-Jeong Jang, Seung-Beom Choi, Ui-Beom Park, Sang-Hyung Lee, Yong-Seok Heo
The High-Resolution Structure Reveals Remarkable Similarity in PD-1 Binding of Cemiplimab and Dostarlimab, the FDA-Approved Antibodies for Cancer Immunotherapy. Biomedicines 10 (12) (2022)
Tae-Jun Jeong, Hyun Tae Lee, Nahyeon Gu, Yu-Jeong Jang, Seung-Beom Choi, Ui-Beom Park, Sang-Hyung Lee, Yong-Seok Heo
The High-Resolution Structure Reveals Remarkable Similarity in PD-1 Binding of Cemiplimab and Dostarlimab, the FDA-Approved Antibodies for Cancer Immunotherapy. Biomedicines 10 (12) (2022)
Hyun Tae Lee, Sang Hyung Lee, Yong-Seok Heo
Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology. Molecules (Basel, Switzerland) 24 (6) (2019)